185 related articles for article (PubMed ID: 25086585)
1. Cost effectiveness of renal denervation therapy for the treatment of resistant hypertension in the UK.
Gladwell D; Henry T; Cook M; Akehurst R
Appl Health Econ Health Policy; 2014 Dec; 12(6):611-22. PubMed ID: 25086585
[TBL] [Abstract][Full Text] [Related]
2. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.
Dorenkamp M; Bonaventura K; Leber AW; Boldt J; Sohns C; Boldt LH; Haverkamp W; Frei U; Roser M
Eur Heart J; 2013 Feb; 34(6):451-61. PubMed ID: 23091202
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.
Geisler BP; Egan BM; Cohen JT; Garner AM; Akehurst RL; Esler MD; Pietzsch JB
J Am Coll Cardiol; 2012 Oct; 60(14):1271-7. PubMed ID: 22981547
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of renal denervation therapy for the treatment of resistant hypertension in The Netherlands.
Henry TL; De Brouwer BF; Van Keep MM; Blankestijn PJ; Bots ML; Koffijberg H
J Med Econ; 2015 Jan; 18(1):76-87. PubMed ID: 25367314
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario.
Chowdhury EK; Reid CM; Zomer E; Kelly DJ; Liew D
Am J Hypertens; 2018 Sep; 31(10):1156-1163. PubMed ID: 30010694
[TBL] [Abstract][Full Text] [Related]
6. Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension.
Taylor RS; Bentley A; Metcalfe K; Lobo MD; Kirtane AJ; Azizi M; Clark C; Murphy K; Boer JH; van Keep M; Ta AT; Barman NC; Schwab G; Akehurst R; Schmieder RE
Pharmacoecon Open; 2024 Jan; ():. PubMed ID: 38289517
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence.
Sharp ASP; Cao KN; Esler MD; Kandzari DE; Lobo MD; Schmieder RE; Pietzsch JB
Eur Heart J Qual Care Clin Outcomes; 2024 Jan; ():. PubMed ID: 38196127
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A
J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441
[TBL] [Abstract][Full Text] [Related]
9. SYMPLICITY HTN-Japan - First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients - .
Kario K; Ogawa H; Okumura K; Okura T; Saito S; Ueno T; Haskin R; Negoita M; Shimada K;
Circ J; 2015; 79(6):1222-9. PubMed ID: 25912693
[TBL] [Abstract][Full Text] [Related]
10. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
Kandzari DE; Bhatt DL; Brar S; Devireddy CM; Esler M; Fahy M; Flack JM; Katzen BT; Lea J; Lee DP; Leon MB; Ma A; Massaro J; Mauri L; Oparil S; O'Neill WW; Patel MR; Rocha-Singh K; Sobotka PA; Svetkey L; Townsend RR; Bakris GL
Eur Heart J; 2015 Jan; 36(4):219-27. PubMed ID: 25400162
[TBL] [Abstract][Full Text] [Related]
11. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels.
Lambert T; Nahler A; Reiter C; Gammer V; Blessberger H; Kammler J; Grund M; Saleh K; Schwarz S; Steinwender C
Catheter Cardiovasc Interv; 2015 Sep; 86(3):E126-30. PubMed ID: 26033366
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of renin-guided treatment of hypertension.
Smith SM; Campbell JD
Am J Hypertens; 2013 Nov; 26(11):1303-10. PubMed ID: 24048147
[TBL] [Abstract][Full Text] [Related]
13. Sufficient and Persistent Blood Pressure Reduction in the Final Long-Term Results From SYMPLICITY HTN-Japan - Safety and Efficacy of Renal Denervation at 3 Years.
Kario K; Yamamoto E; Tomita H; Okura T; Saito S; Ueno T; Yasuhara D; Shimada K;
Circ J; 2019 Feb; 83(3):622-629. PubMed ID: 30760655
[TBL] [Abstract][Full Text] [Related]
14. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M
Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238
[TBL] [Abstract][Full Text] [Related]
15. Renal denervation.
Olsen LK; Kamper AL; Svendsen JH; Feldt-Rasmussen B
Eur J Intern Med; 2015 Mar; 26(2):95-105. PubMed ID: 25676808
[TBL] [Abstract][Full Text] [Related]
16. A modeled economic evaluation of sevelamer for treatment of hyperphosphatemia associated with chronic kidney disease among patients on dialysis in the United Kingdom.
Bernard L; Mendelssohn D; Dunn E; Hutchison C; Grima DT
J Med Econ; 2013; 16(1):1-9. PubMed ID: 22857538
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
[TBL] [Abstract][Full Text] [Related]
18. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
[TBL] [Abstract][Full Text] [Related]
20. Renal denervation in patients with resistant hypertension: six-month results.
Dores H; de Sousa Almeida M; de Araújo Gonçalves P; Branco P; Gaspar A; Sousa H; Canha Gomes A; Andrade MJ; Carvalho MS; Campante Teles R; Raposo L; Mesquita Gabriel H; Pereira Machado F; Mendes M
Rev Port Cardiol; 2014 Apr; 33(4):197-204. PubMed ID: 24472425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
